|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Labianca R, Beretta GD, Kildani B, Milesi
L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, et
al: Colon cancer. Crit Rev Oncol Hematol. 74:106–133. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li M and Gu J: Changing patterns of
colorectal cancer in China over a period of 20 years. World J
Gastroenterol. 11:4685–4688. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ministry of Health and Welfare: The cancer
mortality report of the Department of Health. Taiwan: 2014
|
|
6
|
Camp ER and Ellis LM: CCR 20th Anniversary
Commentary: RAS as a Biomarker for EGFR-targeted therapy for
colorectal cancer-from concept to practice. Clin Cancer Res.
21:3578–3580. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hazan RB, Qiao R, Keren R, Badano I and
Suyama K: Cadherin switch in tumor progression. Ann N Y Acad Sci.
1014:155–163. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Makrilia N, Kollias A, Manolopoulos L and
Syrigos K: Cell adhesion molecules: Role and clinical significance
in cancer. Cancer Invest. 27:1023–1037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Babykutty S, Suboj P, Srinivas P, Nair AS,
Chandramohan K and Gopala S: Insidious role of nitric oxide in
migration/invasion of colon cancer cells by upregulating MMP-2/9
via activation of cGMP-PKG-ERK signaling pathways. Clin Exp
Metastasis. 29:471–492. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dung TD, Feng CC, Kuo WW, Pai P, Chung LC,
Chang SH, Hsu HH, Tsai FJ, Lin YM and Huang CY: Suppression of
plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum
avicennae extract to inhibit the HA22T human hepatocellular
carcinoma cell migration and invasion effects in vitro and in vivo
via phosphatase 2A activation. Biosci Biotechnol Biochem.
77:1814–1821. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liotta LA, Tryggvason K, Garbisa S, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kalluri R: EMT: When epithelial cells
decide to become mesenchymal-like cells. J Clin. Invest.
119:1417–1419. 2009. View
Article : Google Scholar
|
|
15
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kortylewski M, Xin H, Kujawski M, Lee H,
Liu Y, Harris T, Drake C, Pardoll D and Yu H: Regulation of the
IL-23 and IL-12 balance by Stat3 signaling in the tumor
microenvironment. Cancer Cell. 15:114–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rieger-Christ KM, Lee P, Zagha R,
Kosakowski M, Moinzadeh A, Stoffel J, Ben-Ze'ev A, Libertino JA and
Summerhayes IC: Novel expression of N-cadherin elicits in vitro
bladder cell invasion via the Akt signaling pathway. Oncogene.
23:4745–4753. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tong W, Wang Q, Sun D and Suo J: Curcumin
suppresses colon cancer cell invasion via AMPK-induced inhibition
of NF-κB, uPA activator and MMP9. Oncol Lett. 12:4139–4146. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han M, Song Y and Zhang X: Quercetin
suppresses the migration and invasion in human colon cancer Caco-2
cells through regulating toll-like receptor 4/nuclear factor-kappa
B Pathway. Pharmacogn Mag. 12 Suppl 2:S237–S244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yun JH, Kim KA, Yoo G, Kim SY, Shin JM,
Kim JH, Jung SH, Kim J and Nho CW: Phenethyl isothiocyanate
suppresses cancer stem cell properties in vitro and in a xenograft
model. Phytomedicine. 30:42–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kuo PL and Lin CC: Tetrandrine-induced
cell cycle arrest and apoptosis in Hep G2 cells. Life Sci.
73:243–252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee JH, Kang GH, Kim KC, Kim KM, Park DI,
Choi BT, Kang HS, Lee YT and Choi YH: Tetrandrine-induced cell
cycle arrest and apoptosis in A549 human lung carcinoma cells. Int
J Oncol. 21:1239–1244. 2002.PubMed/NCBI
|
|
24
|
Meng LH, Zhang H, Hayward L, Takemura H,
Shao RG and Pommier Y: Tetrandrine induces early G1 arrest in human
colon carcinoma cells by down-regulating the activity and inducing
the degradation of G1-S-specific cyclin-dependent kinases and by
inducing p53 and p21Cip1. Cancer Res. 64:9086–9092. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen XL, Ren KH, He HW and Shao RG:
Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1
arrest and apoptosis. Cancer Biol Ther. 7:1073–1078. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McCubrey JA, Basecke J, Cervello M,
Martelli AM and Franklin RA: GSK-3beta is a critical mediator of
tetrandrine induced cell cycle arrest and cytotoxicity. Cancer Biol
Ther. 7:10792008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu W, Kou B, Ma ZK, Tang XS, Lv C, Ye M,
Chen JQ, Li L, Wang XY and He DL: Tetrandrine suppresses
proliferation, induces apoptosis, and inhibits migration and
invasion in human prostate cancer cells. Asian J Androl.
17:850–853. 2015.PubMed/NCBI
|
|
28
|
Gao JL, Ji X, He TC, Zhang Q, He K, Zhao
Y, Chen SH and Lv GY: Tetrandrine suppresses cancer angiogenesis
and metastasis in 4T1 tumor bearing mice. Evid Based Complement.
Alternat Med. 2013:2650612013.
|
|
29
|
Horng CT, Yang JS, Chiang JH, Lu CC, Lee
CF, Chiang NN and Chen FA: Inhibitory effects of tetrandrine on
epidermal growth factor-induced invasion and migration in HT29
human colorectal adenocarcinoma cells. Mol Med Rep. 13:1003–1009.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu H, Hou Z, Zhang H, Kong H, Li X, Wang H
and Xie W: An efficient Trojan delivery of tetrandrine by
poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL)
nanoparticles shows enhanced apoptotic induction of lung cancer
cells and inhibition of its migration and invasion. Int J
Nanomedicine. 9:231–242. 2014.PubMed/NCBI
|
|
31
|
Zhang JS, Li DM, Ma Y, He N, Gu Q, Wang
FS, Jiang SQ, Chen BQ and Liu JR: γ-Tocotrienol induces
paraptosis-like cell death in human colon carcinoma SW620 cells.
PLoS One. 8:e577792013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang YM, Velmurugan BK, Kuo WW, Chen YS,
HO TJ, Tsai CT, Ye CX, Tsai CH, Tsai FJ and Huang CY: Inhibitory
effect of alpinate Oxyphyllae fructus extracts on Ang II-induced
cardiac pathological remodeling-related pathways in H9c2
cardiomyoblast cells. Biomedicine. 3:148–152. 2013. View Article : Google Scholar
|
|
33
|
Park WH, Seol JG, Kim ES, Hyun JM, Jung
CW, Lee CC, Kim BK and Lee YY: Arsenic trioxide-mediated growth
inhibition in MC/CAR myeloma cells via cell cycle arrest in
association with induction of cyclin-dependent kinase inhibitor,
p21, and apoptosis. Cancer Res. 60:3065–3071. 2000.PubMed/NCBI
|
|
34
|
Lai KC, Hsu SC, Yang JS, Yu CC, Lein JC
and Chung JG: Diallyl trisulfide inhibits migration, invasion and
angiogenesis of human colon cancer HT-29 cells and umbilical vein
endothelial cells, and suppresses murine xenograft tumour growth. J
Cell Mol Med. 19:474–484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Verhoeff JJ, van Tellingen O, Claes A,
Stalpers LJ, van Linde ME, Richel DJ, Leenders WP and van Furth WR:
Concerns about anti-angiogenic treatment in patients with
glioblastoma multiforme. BMC Cancer. 9:4442009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen
LK, Chu NM, Tan TD, Tsou MH and Huang AT: Prognostic features and
treatment outcome in locoregionally advanced nasopharyngeal
carcinoma following concurrent chemotherapy and radiotherapy. Int J
Radiat Oncol Biol Phys. 41:755–762. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gupta GP and Massague J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang YL, Chu YL, Ho CT, Chung JG, Lai CI,
Su YC, Kuo YH and Sheen LY: Antcin K, an active triterpenoid from
the fruiting bodies of basswood-cultivated antrodia cinnamomea,
inhibits metastasis via suppression of integrin-mediated adhesion,
migration, and invasion in human hepatoma cells. J Agric Food Chem.
63:4561–4569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Park SJ, Kong HK, Kim YS, Lee YS and Park
JH: Inhibition of S-adenosylhomocysteine hydrolase decreases cell
mobility and cell proliferation through cell cycle arrest. Am J
Cancer Res. 5:2127–2138. 2015.PubMed/NCBI
|
|
40
|
Wu ZY, Lien JC, Huang YP, Liao CL, Lin JJ,
Fan MJ, Ko YC, Hsiao YP, Lu HF and Chung JG: Casticin inhibits
A375.S2 human melanoma cell migration/invasion through
downregulating NF-κB and matrix metalloproteinase-2 and −1.
Molecules. 21:3842016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ji BC, Hsiao YP, Tsai CH, Chang SJ, Hsu
SC, Liu HC, Huang YP, Lien JC and Chung JG: Cantharidin impairs
cell migration and invasion of A375.S2 human melanoma cells by
suppressing MMP-2 and −9 through PI3K/NF-κB signaling pathways.
Anticancer Res. 35:729–738. 2015.PubMed/NCBI
|
|
42
|
Liao CL, Lai KC, Huang AC, Yang JS, Lin
JJ, Wu SH, Wood Gibson W, Lin JG and Chung JG: Gallic acid inhibits
migration and invasion in human osteosarcoma U-2 OS cells through
suppressing the matrix metalloproteinase-2/-9, protein kinase B
(PKB) and PKC signaling pathways. Food Chem Toxicol. 50:1734–1740.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shia CS, Suresh G, Hou YC, Lin YC, Chao PD
and Juang SH: Suppression on metastasis by rhubarb through
modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: An
ex vivo approach. J Ethnopharmacol. 133:426–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
Outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.PubMed/NCBI
|
|
46
|
Birkedal-Hansen H, Moore WG, Bodden MK,
Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA: Matrix
metalloproteinases: A review. Crit Rev Oral Biol Med. 4:197–250.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dutta A, Li J, Lu H, Akech J, Pratap J,
Wang T, Zerlanko BJ, FitzGerald TJ, Jiang Z, Birbe R, et al:
Integrin αvβ6 promotes an osteolytic program in cancer cells by
upregulating MMP2. Cancer Res. 74:1598–1608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lai KC, Hsu SC, Kuo CL, Ip SW, Yang JS,
Hsu YM, Huang HY, Wu SH and Chung JG: Phenethyl isothiocyanate
inhibited tumor migration and invasion via suppressing multiple
signal transduction pathways in human colon cancer HT29 cells. J
Agric Food Chem. 58:11148–11155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Matsumura T, Sugimachi K, Takahashi Y,
Uchi R, Sawada G, Ueda M, Hirata H, Sakimura S, Ueo H, Takano Y, et
al: Clinical significance of GAB2, a scaffolding/docking protein
acting downstream of EGFR in human colorectal cancer. Ann Surg
Oncol. 21 Suppl 4:S743–S749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Waseem T, Duxbury M, Ashley SW and
Robinson MK: Ghrelin promotes intestinal epithelial cell
proliferation through PI3K/Akt pathway and EGFR trans-activation
both converging to ERK 1/2 phosphorylation. Peptides. 52:113–121.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hsu HH, Hu WS, Lin YM, Kuo WW, Chen LM,
Chen WK, Hwang JM, Tsai FJ, Liu CJ and Huang CY: JNK suppression is
essential for 17β-estradiol inhibits prostaglandin E2-induced uPA
and MMP-9 expressions and cell migration in human LoVo colon cancer
cells. J Biomed Sci. 18:612011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xiang T, Fei R, Wang Z, Shen Z, Qian J and
Chen W: Nicotine enhances invasion and metastasis of human
colorectal cancer cells through the nicotinic acetylcholine
receptor downstream p38 MAPK signaling pathway. Oncol Rep.
35:205–210. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhao GY, Ding JY, Lu CL, Lin ZW and Guo J:
The overexpression of 14-3-3ζ and Hsp27 promotes non-small cell
lung cancer progression. Cancer. 120:652–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jeong D, Park S, Kim H, Kim CJ, Ahn TS,
Bae SB, Kim HJ, Kim TH, Im J and Lee MS: RhoA is associated with
invasion and poor prognosis in colorectal cancer. Int J Oncol.
48:714–722. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Clevers H: Wnt/β-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
White BD, Chien AJ and Dawson DW:
Dysregulation of Wnt/β-catenin signaling in gastrointestinal
cancers. Gastroenterology. 142:219–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Norwood MG, Bailey N, Nanji M, Gillies RS,
Nicholson A, Ubhi S, Darnton JJ, Steyn RS, Womack C, Hughes A, et
al: Cytoplasmic beta-catenin accumulation is a good prognostic
marker in upper and lower gastrointestinal adenocarcinomas.
Histopathology. 57:101–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kobayashi M, Honma T, Matsuda Y, Suzuki Y,
Narisawa R, Ajioka Y and Asakura H: Nuclear translocation of
beta-catenin in colorectal cancer. Br J Cancer. 82:1689–1693.
2000.PubMed/NCBI
|
|
59
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Yamamoto Y and Gaynor RB: Therapeutic
potential of inhibition of the NF-kappaB pathway in the treatment
of inflammation and cancer. J Clin Invest. 107:135–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fryknas M, Dhar S, Oberg F, Rickardson L,
Rydåker M, Göransson H, Gustafsson M, Pettersson U, Nygren P,
Larsson R and Isaksson A: STAT1 signaling is associated with
acquired crossresistance to doxorubicin and radiation in myeloma
cell lines. Int J Cancer. 120:189–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Roberts D, Schick J, Conway S, Biade S,
Laub PB, Stevenson JP, Hamilton TC, O'Dwyer PJ and Johnson SW:
Identification of genes associated with platinum drug sensitivity
and resistance in human ovarian cancer cells. Br J Cancer.
92:1149–1158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Hasegawa K, Ichikawa W, Fujita T, Ohno R,
Okusa T, Yoshinaga K and Sugihara K: Expression of cyclooxygenase-2
(COX-2) mRNA in human colorectal adenomas. Eur J Cancer.
37:1469–1474. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Peek RM Jr: Prevention of colorectal
cancer through the use of COX-2 selective inhibitors. Cancer
Chemother Pharmacol. 54 Suppl 1:S50–S56. 2004.PubMed/NCBI
|
|
65
|
Dempke W, Rie C, Grothey A and Schmoll HJ:
Cyclooxygenase-2: A novel target for cancer chemotherapy? J Cancer
Res Clin Oncol. 127:411–417. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Giercksky KE: COX-2 inhibition and
prevention of cancer. Best Pract Res Clin Gastroenterol.
15:821–833. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang H and Sun XF: Overexpression of
cyclooxygenase-2 correlates with advanced stages of colorectal
cancer. Am J Gastroenterol. 97:1037–1041. 2002. View Article : Google Scholar : PubMed/NCBI
|
